Hematopoietic stem cell gene therapy as a therapeutic approach for CDKL5 Deficiency Disorder
Awardee: Joseph Anderson, PhD
Institution: University of California, Davis
Award Amount: $150,000
Funding Period: May 1, 2022 - April 31, 2023
Previous
Previous
A functional genomics approach to dissect the molecular bases of CDKL5 Deficiency Disorder
Next
Next